Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Miranda Boyun Lam, M.D.

Concepts (160)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology520235631.860 Why?
Medicare16202467701.250 Why?
Accreditation220244731.210 Why?
Neoplasms132024221731.080 Why?
Medical Oncology4202423210.820 Why?
Insurance Coverage4202219400.770 Why?
Medicaid5202228180.750 Why?
Insurance Carriers120221560.730 Why?
Prospective Payment System120211360.700 Why?
Health Care Costs3202332420.680 Why?
Radiotherapy3202114980.670 Why?
Patient Protection and Affordable Care Act4202211880.610 Why?
Retroperitoneal Neoplasms120213330.590 Why?
Hemangiosarcoma120202150.590 Why?
Hospice Care220226780.580 Why?
Health Expenditures3202123660.580 Why?
United States272024723400.570 Why?
Healthcare Disparities5202333580.550 Why?
Vulnerable Populations120217030.510 Why?
Medically Uninsured120218360.500 Why?
Health Status Disparities2202318530.460 Why?
Hospitals5202438830.450 Why?
Quality Indicators, Health Care1202117920.380 Why?
Terminal Care2202117610.370 Why?
Patient Admission1201813670.370 Why?
Delivery of Health Care4202453370.370 Why?
Lung Neoplasms52024133810.360 Why?
Sarcoma1202118010.340 Why?
Surgical Procedures, Operative1202019240.320 Why?
Carcinoma, Non-Small-Cell Lung3202453140.320 Why?
Uterine Cervical Neoplasms1202120200.320 Why?
Lymph Nodes1202034650.310 Why?
Quality Assurance, Health Care1201821690.300 Why?
Fee-for-Service Plans320217000.280 Why?
Death220226760.280 Why?
Neoplasm Staging82024111200.280 Why?
Humans4720247615960.240 Why?
Private Practice220211530.240 Why?
Aged1920241693100.210 Why?
Radiotherapy Planning, Computer-Assisted4202316600.210 Why?
Telephone120166270.200 Why?
Combined Modality Therapy3202185270.190 Why?
Colonic Neoplasms2202325390.180 Why?
National Cancer Institute (U.S.)120222970.180 Why?
Colorectal Neoplasms1202069380.180 Why?
Skin Neoplasms1202058210.180 Why?
Chondrosarcoma120232960.170 Why?
Radiotherapy Dosage3202328980.170 Why?
Pancreatic Neoplasms3202353680.170 Why?
Retreatment120215980.170 Why?
Health Services Accessibility3202254400.170 Why?
Terminally Ill120212400.160 Why?
Cost Savings220219130.160 Why?
Career Choice120157560.160 Why?
Medicare Part D120233550.160 Why?
Eligibility Determination120224210.160 Why?
Joint Commission on Accreditation of Healthcare Organizations12018920.160 Why?
Ownership120213390.160 Why?
Quality of Health Care2202143310.160 Why?
Rural Health Services120213840.140 Why?
Carcinoma in Situ120237910.140 Why?
Radiosurgery2202313420.140 Why?
Scalp120203890.140 Why?
Breast Neoplasms22023210190.140 Why?
Ambulatory Care Facilities120239350.140 Why?
Databases, Factual2202079680.130 Why?
Patients120239070.130 Why?
Spinal Neoplasms120237160.130 Why?
Reimbursement, Incentive120215430.130 Why?
Postoperative Period1202018140.130 Why?
Cross-Sectional Studies32021261290.120 Why?
Leukemia1202315220.120 Why?
Rectal Neoplasms1201411570.120 Why?
Gastrointestinal Neoplasms120229540.120 Why?
Coronary Artery Bypass1202421880.120 Why?
Logistic Models22020132550.120 Why?
Confidence Intervals1201929270.110 Why?
Male1320243608460.100 Why?
Female1220233927050.100 Why?
Lymphoma, Non-Hodgkin1202013740.100 Why?
International Classification of Diseases120189100.100 Why?
Inpatients1202325480.100 Why?
Kallikreins120132200.100 Why?
Internship and Residency2201558820.090 Why?
Disease Management1202125080.090 Why?
Insurance, Health1202224990.090 Why?
Retrospective Studies102024806470.080 Why?
Linear Models1201958720.080 Why?
Biopsy1202167660.080 Why?
Mortality1202029020.080 Why?
Survival Rate22021127230.080 Why?
Small Cell Lung Carcinoma120134230.080 Why?
Fluorodeoxyglucose F182201320090.070 Why?
Clinical Trials as Topic1201380020.070 Why?
Diagnostic Imaging1202135300.070 Why?
Positron-Emission Tomography2201364840.070 Why?
Prostatic Neoplasms22023111220.070 Why?
Liver Neoplasms1202243170.070 Why?
Middle Aged820222209210.070 Why?
Palliative Care1202135980.070 Why?
Aged, 80 and over42019589840.060 Why?
Leadership1201513850.060 Why?
Odds Ratio1201896470.060 Why?
Follow-Up Studies42021391060.060 Why?
Neoplasm Recurrence, Local4202092800.060 Why?
Adenocarcinoma2202063450.060 Why?
Longitudinal Studies12020146080.060 Why?
Prognosis32021296290.060 Why?
Head and Neck Neoplasms1201828940.060 Why?
Prostate-Specific Antigen1201324690.050 Why?
Diagnosis-Related Groups120244490.050 Why?
Curriculum1201537430.050 Why?
Hematopoietic Stem Cell Transplantation1202056720.050 Why?
Treatment Outcome42021646850.050 Why?
Neoadjuvant Therapy2202328280.050 Why?
Prevalence12018157330.050 Why?
Radiotherapy, Adjuvant1201417840.040 Why?
Brachytherapy1201512230.040 Why?
Postoperative Care1201414680.040 Why?
Costs and Cost Analysis1202316680.030 Why?
Pneumonectomy1202411190.030 Why?
Antineoplastic Agents12019136420.030 Why?
Pancreaticoduodenectomy120205090.030 Why?
Nasopharyngeal Neoplasms120182900.030 Why?
Spine1202311180.030 Why?
Pancreatectomy120208110.030 Why?
Multivariate Analysis22023120590.030 Why?
Chemotherapy, Adjuvant1201435140.030 Why?
Qualitative Research1201630250.030 Why?
Transplantation, Autologous1202021150.030 Why?
Adult520222212100.030 Why?
Preoperative Care1201422420.030 Why?
Cardiovascular Diseases12020155020.030 Why?
Breast1202319670.030 Why?
Radiopharmaceuticals2201326500.030 Why?
Societies, Medical1201539050.030 Why?
Radiometry120188130.030 Why?
Carcinoma, Large Cell120131130.030 Why?
Magnetic Resonance Spectroscopy1202337690.030 Why?
Radiotherapy, Intensity-Modulated120188010.020 Why?
Radiation Injuries1201811890.020 Why?
Stents1202331790.020 Why?
Echocardiography1202349890.020 Why?
Tomography, X-Ray Computed12013205680.020 Why?
Survival Analysis12023100900.020 Why?
Biomedical Research1201534290.020 Why?
Disease-Free Survival1202068150.020 Why?
Kaplan-Meier Estimate1201864840.020 Why?
Neoplasm Metastasis1201849150.020 Why?
Cohort Studies22022414950.020 Why?
Lymphatic Metastasis1201329150.020 Why?
Time Factors12016399690.010 Why?
Models, Statistical1201850790.010 Why?
Hospitalization12023107210.010 Why?
Antineoplastic Combined Chemotherapy Protocols12020117420.010 Why?
Proportional Hazards Models12013124630.010 Why?
Carcinoma, Squamous Cell1201340240.010 Why?
Young Adult12018592600.010 Why?
Adolescent12018883260.010 Why?
Prospective Studies12013544230.000 Why?
Lam's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (160)
Explore
_
Co-Authors (52)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.